ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
Ph.D
Saved in:
Main Author: | CHEN LUXI |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/47507 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
ROLE OF ANNEXIN-1 IN PATHOGEN RECOGNITION AND IMMUNE RESPONSE
by: SHU SHIN LA
Published: (2013) -
EZH2 AND FOXM1 CROSSTALK IN TRIPLE NEGATIVE BREAST CANCER
by: SYLVIA MAHARA
Published: (2016) -
PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.
by: Chen, Luxi, et al.
Published: (2020) -
THE ROLE OF ANNEXIN-1 IN THE REGULATION OF INFLAMMATORY STRESS RESPONSE IN MACROPHAGES
by: SUNITHA NAIR
Published: (2014) -
Functional regulation of PPARs through post-translational modifications
by: Brunmeir R., et al.
Published: (2019)